Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation.

MLA

Lee, Sunyoung, et al. “Gadoxetic Acid-Enhanced MRI as a Predictor of Recurrence of HCC after Liver Transplantation.” European Radiology, vol. 30, no. 2, Feb. 2020, pp. 987–95. EBSCOhost, https://doi.org/10.1007/s00330-019-06424-0.

APA

Lee, S., Kim, K. W., Jeong, W. K., Kim, M.-J., Choi, G. H., Choi, J. S., Song, G.-W., & Lee, S.-G. (2020). Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation. European Radiology, 30(2), 987–995. https://doi.org/10.1007/s00330-019-06424-0

Chicago

Lee, Sunyoung, Kyoung Won Kim, Woo Kyoung Jeong, Myeong-Jin Kim, Gi Hong Choi, Jin Sub Choi, Gi-Won Song, and Sung-Gyu Lee. 2020. “Gadoxetic Acid-Enhanced MRI as a Predictor of Recurrence of HCC after Liver Transplantation.” European Radiology 30 (2): 987–95. doi:10.1007/s00330-019-06424-0.